title: Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
authors.affiliation: 1 Tufts Medical Center Boston, Massachusetts.
authors.forename: Nicholas S
authors.initials: NS
authors.lastname: Hill
authors.affiliation: 2 University of Colorado School of Medicine Denver, Colorado.
authors.forename: David
authors.initials: D
authors.lastname: Badesch
authors.affiliation: 3 Allegheny Health Network Pittsburgh, Pennsylvania.
authors.forename: Raymond L
authors.initials: RL
authors.lastname: Benza
authors.affiliation: 4 Boston University School of Medicine Boston, Massachusetts.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: D'Eletto
authors.affiliation: 4 Boston University School of Medicine Boston, Massachusetts.
authors.forename: Harrison W
authors.initials: HW
authors.lastname: Farber
authors.affiliation: 5 University of Chicago Chicago, Illinois.
authors.forename: Mardi
authors.initials: M
authors.lastname: Gomberg-Maitland
authors.affiliation: 6 Johns Hopkins University Baltimore, Maryland.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Hassoun
authors.affiliation: 1 Tufts Medical Center Boston, Massachusetts.
authors.forename: Ioana
authors.initials: I
authors.lastname: Preston
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D065128:Endothelin Receptor Antagonists / Q000627:therapeutic use*; D011464:Epoprostenol / Q000031:analogs & derivatives*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D011720:Pyrazoles; D011743:Pyrimidines; D013449:Sulfonamides; D011464:Epoprostenol